Evaluation of Three Mutations in Codon 385 of Glucose-6-Phosphate Dehydrogenase via Biochemical and In Silico Analysis.
Adriana G��lvez-Ram��rez, Abigail Gonz��lez-Valdez, Beatriz Hern��ndez-Ochoa, Luis Miguel Canseco-��vila, Alexander L��pez-Roblero, Roberto Arreguin-Espinosa, Ver��nica P��rez de la Cruz, Elizabeth Hern��ndez-Urzua, Noemi C��rdenas-Rodr��guez, Sergio Enr��quez-Flores, Ignacio De la Mora-De la Mora, Abraham Vidal-Limon, Sa��l G��mez-Manzo
Author Information
Adriana G��lvez-Ram��rez: Laboratorio de Bioqu��mica Gen��tica, Instituto Nacional de Pediatr��a, Secretar��a de Salud, Mexico City 04530, Mexico.
Abigail Gonz��lez-Valdez: Departamento de Biolog��a Molecular y Biotecnolog��a, Instituto de Investigaciones Biom��dicas, Universidad Nacional Aut��noma de M��xico, Mexico City 04510, Mexico.
Beatriz Hern��ndez-Ochoa: Laboratorio de Inmunoqu��mica, Hospital Infantil de M��xico Federico G��mez, Secretar��a de Salud, Mexico City 06720, Mexico.
Luis Miguel Canseco-��vila: Facultad de Ciencias Qu��micas, Campus IV, Universidad Aut��noma de Chiapas, Tapachula City 30580, Mexico. ORCID
Alexander L��pez-Roblero: Facultad de Ciencias Qu��micas, Campus IV, Universidad Aut��noma de Chiapas, Tapachula City 30580, Mexico. ORCID
Roberto Arreguin-Espinosa: Departamento de Qu��mica de Biomacromol��culas, Instituto de Qu��mica, Universidad Nacional Aut��noma de M��xico, Mexico City 04510, Mexico. ORCID
Ver��nica P��rez de la Cruz: Neurobiochemistry and Behavior Laboratory, National Institute of Neurology and Neurosurgery "Manuel Velasco Su��rez", Mexico City 14269, Mexico. ORCID
Elizabeth Hern��ndez-Urzua: Laboratorio de Toxicolog��a Gen��tica, Instituto Nacional de Pediatr��a, Secretar��a de Salud, Mexico City 04530, Mexico.
Noemi C��rdenas-Rodr��guez: Laboratorio de Neurociencias, Instituto Nacional de Pediatr��a, Secretar��a de Salud, Mexico City 04530, Mexico. ORCID
Sergio Enr��quez-Flores: Laboratorio de Biomol��culas y Salud Infantil, Instituto Nacional de Pediatr��a, Secretar��a de Salud, Mexico City 04530, Mexico. ORCID
Ignacio De la Mora-De la Mora: Laboratorio de Biomol��culas y Salud Infantil, Instituto Nacional de Pediatr��a, Secretar��a de Salud, Mexico City 04530, Mexico. ORCID
Abraham Vidal-Limon: Red de Estudios Moleculares Avanzados, Cl��ster Cient��fico y Tecnol��gico BioMimic, Instituto de Ecolog��a A.C. (INECOL), Carretera Antigua a Coatepec 351, El Haya, Xalapa 91073, Mexico. ORCID
Sa��l G��mez-Manzo: Laboratorio de Bioqu��mica Gen��tica, Instituto Nacional de Pediatr��a, Secretar��a de Salud, Mexico City 04530, Mexico. ORCID
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an enzymopathy that affects approximately 500 million people worldwide. A great number of mutations in the gene have been described. However, three class A G6PD variants known as G6PD Tomah (C385R), G6PD Kangnam (C385G), and G6PD Madrid (C385W) have been reported to be clinically important due to their associations with severe clinical manifestations such as hemolytic anemia. Therefore, this work aimed to perform, for the first time, biochemical and functional characterizations of these variants. The G6PD variants were cloned and purified for this purpose, followed by analyses of their kinetic parameters and thermal stability, as well as in silico studies. The results showed that the mutations induced changes in the proteins. Regarding the kinetic parameters, it was observed that the three variants showed lower affinities for G6P and NADP, as well as lower thermal stability compared to WT-G6PD. Molecular dynamics simulations showed that C385 mutations induced changes around neighboring amino acids. Metadynamics simulations showed that most remarkable changes account for the binding pocket volumes, particularly in the structural NADP binding site, with a concomitant loss of affinity for catalytic processes.